Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1.
Li X, Xu M, Yang J, Zhou L, Liu L, Li M, Wang S, Liu MQ, Huang Z, Zhang Z, Liu S, Hu Y, Lin H, Liu B, Sun Y, Wu Q, Shi ZL, Lan K, Chen Y, Yan H, Chen YQ.
Li X, et al. Among authors: chen yq, chen y.
Signal Transduct Target Ther. 2024 Apr 27;9(1):114. doi: 10.1038/s41392-024-01822-3.
Signal Transduct Target Ther. 2024.
PMID: 38678055